Tradestie Institutional Equity Comparison Engine

ABVC vs ASTI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABVC Overall Edge

ABVC Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ABVC BioPharma, Inc. Common Stock (ABVC) driven by superior Growth & Margin, Momentum & Technical while ASTI counters with relative strength in Valuation, Options & Structure. Fundamentally, ABVC trades at N/M Forward P/E with 0.0% operating margin (+104.5% YoY revenue) versus ASTI at 14.4x Forward P/E and -2759.6% operating margin (+514.3% YoY). In options structure, ABVC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ASTI sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ASTI
ABVC N/M vs ASTI 14.4x Fwd P/E
Growth & Margin Winner ABVC
Op Margin 0.0% vs -2759.6% ยท YoY +104.5% vs +514.3%
Momentum & Technical Winner ABVC
1Y -68.2% vs -52.4% ยท 52W Pos 7% vs 0%
Options & Structure Winner ASTI
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (<1st %ile IV)
ABVC NASDAQ
ABVC BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$0.87
-1.56% 1D
Market Cap $23.9M
1M Return -17.28%
1Y Return -68.15%
Forward P/E N/M
Unified AI Score
47.4 / 100 HOLD
Tech 43.0 Fund 50.0 Flow 50.0 Mom 60.0
ASTI NASDAQ
Ascent Solar Technologies, Inc. Common Stock
Semiconductors & Related Devices
$0.77
-9.55% 1D
Market Cap $12.6M
1M Return -56.38%
1Y Return -52.35%
Forward P/E 14.4x
Unified AI Score
44.5 / 100 HOLD
Tech 25.0 Fund 46.0 Flow 59.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABVC -68.15% ASTI -52.35% Spread: +15.8 pp (ASTI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABVC TTM Op. Margin: 0.0% ASTI TTM Op. Margin: -2759.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVC vs ASTI. Trailing 12-month operating profitability (ABVC 0.0% vs ASTI -2759.6%) and valuation multiples (ABVC N/M vs ASTI 14.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABVC (6) vs ASTI (3)
Institutional Metric ABVC ASTI Criterion Row Winner
Market Capitalization Scale $23.9M $12.6M Larger Scale ABVC
Trailing P/E Ratio Valuation N/M 14.4x Lower Multiple ASTI
Forward P/E Ratio Valuation N/M 14.4x Lower Multiple ASTI
Revenue Growth (YoY) Growth +104.5% +514.3% Higher Growth ASTI
Operating Margin (TTM) Profitability 0.0% -2759.6% Higher Margin ABVC
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -52.7% -111.3% Higher ROE ABVC
52-Week Range Position Momentum 7% ($1โ€“$3) 0% ($1โ€“$10) Stronger Trend ABVC
Beta / 30D Volatility Risk Regime 1.24ฮฒ ยท 44% Vol 4.37ฮฒ ยท 123% Vol Lower Realized Risk ABVC
Unified Institutional Score Composite Signal 47.4 / 100 (HOLD) 44.5 / 100 (HOLD) Higher Composite ABVC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABVC vs ASTI Buy Guide
ABVC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ABVC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ASTI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live ASTI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABVC nor ASTI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.